[at Motley Fool] – Chelsea, Merck, and Johnson & Johnson state their cases for approval in front of an FDA panel. Here’s everything you need to know to stay ahead of the game.
Read more on this.
Johnson & … [visit site to read more]
Similar posts:- Merck & Co. Inc. (NYSE:MRK) ~ A Busy Week for Cardiac Health at the FDA
- Johnson & Johnson (NYSE:JNJ) | Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
- Stocks rise on health plan approval in US, USD loses strength